Placebos may be more effective for some psychiatric conditions and less effective for others, a new study suggests.
Compared to patients with panic disorder or schizophrenia, those with depression or attention-deficit/hyperactivity disorder (ADHD) are less likely to drop out of clinical trials when assigned to the placebo group.





